BDH Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: BDH Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $1.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

BDH Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.5M Trade | TransData Nexus

BDH Healthcare Private Limited

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $1.5M Total Trade · DGFT Verified

BDH Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.5M across 2 products in 2 therapeutic categories. Based on 30 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Celecoxib ($1.1M), Zinc ($350.0K), .

BDH Healthcare Private Limited — Export Portfolio & Destination Treemap

BDH Healthcare Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is BDH Healthcare Private Limited? — Company Overview & Market Position

BDH Healthcare Private Limited, established on July 3, 2013, is a private unlisted pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24233MH2013PTC245156. Its authorized capital stands at ₹5.00 million, with a paid-up capital of ₹4.97 million. The registered office is located at Nair Baug, Second Floor, Akurli Road, Kandivli East, Mumbai, Maharashtra, 400101. BDH Healthcare specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, focusing on drug formulation and development.

What Does BDH Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Celecoxib$1.1M 2Zinc$350.0K

BDH Healthcare Private Limited Therapeutic Categories — 2 Specializations

Product Portfolio — Top 2 by Export Value

BDH Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Celecoxib	Analgesics & Antipyretics	$1.1M	23	0.9%	6
2	Zinc	Vitamins & Supplements	$350.0K	7	0.4%	12

BDH Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.5M. The top category is Analgesics & Antipyretics (76.7% of portfolio), followed by Vitamins & Supplements (23.3%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

BDH Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

BDH Healthcare operates manufacturing facilities in Daman, Daman and Diu, India. The company is classified as a micro enterprise under the MSME category for the financial year 2024-25. Specific details regarding the capacities and specializations of these facilities are not publicly disclosed.

3Key Leadership

The company's leadership comprises two directors:

Ankit Suresh Kachhara: Director since July 3, 2013.

Jayashree Gopakumar Nair: Director since July 3, 2013.

Additionally, Ms. Jayashree Nair serves as the Chairperson and Managing Director of BDH Industries Limited, a related entity.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does BDH Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

BDH Healthcare's export activities are primarily focused on finished pharmaceutical formulations, with a total export value of $1.5 million USD across 30 shipments. The company's product portfolio includes two products across two therapeutic categories:

Top 5 Products:

Celecoxib: $1.1 million USD in exports, ranking #6 with a 0.9% market share.

Zinc: $350,000 USD in exports, ranking #12 with a 0.4% market share.

Top 3 Categories:

Analgesics & Antipyretics: 76.7% of exports.

Vitamins & Supplements: 23.3% of exports.

The company does not hold a market leader position in any of these categories. The portfolio is highly concentrated, with the top 5 products accounting for 100% of exports.

BDH Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

There is no publicly available information regarding BDH Healthcare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. This lack of transparency may indicate limited engagement with the U.S. market or a strategic decision to focus on other regions.

2WHO & EU GMP

BDH Healthcare's export data does not indicate WHO prequalification or EU Good Manufacturing Practice (GMP) certifications. These certifications are essential for accessing certain international markets and ensuring compliance with global quality standards. The absence of such certifications may limit the company's ability to expand its presence in regulated markets.

3CDSCO & Indian Regulatory

BDH Healthcare holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and state drug controllers, as evidenced by its incorporation under the Ministry of Corporate Affairs. The company has also obtained export No Objection Certificates (NOCs) from the Directorate General of Foreign Trade (DGFT), facilitating its export activities.

BDH Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

BDH Healthcare operates in the pharmaceutical industry, exporting finished formulations in categories such as analgesics, antipyretics, vitamins, and supplements. The company's top products, Celecoxib and Zinc, are in direct competition with other manufacturers in these therapeutic areas. However, without specific market share data for these products, a detailed competitive analysis is challenging.

2Key Differentiators

BDH Healthcare's focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, allows it to cater to a broad spectrum of therapeutic needs. The company's specialization in drug formulation and development positions it to adapt to evolving market demands and regulatory requirements.

3Strategic Position

BDH Healthcare's current strategic direction appears to be centered on the export of finished pharmaceutical formulations, with a concentrated product portfolio. The company may benefit from diversifying its product range and exploring new therapeutic areas to enhance its market presence and reduce dependency on a limited number of products.

Buyer Due Diligence Brief — Evaluating BDH Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

BDH Healthcare's export volume of $1.5 million USD across 30 shipments indicates a consistent supply capability. The company's focus on finished formulations suggests a commitment to quality and compliance with international standards. However, the lack of diversification in its product portfolio may impact its ability to meet a broader range of market demands.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure the company holds Good Manufacturing Practice certification from the World Health Organization.

EU GMP Certification: Verify the company's compliance with European Union Good Manufacturing Practice standards.

Frequently Asked Questions — BDH Healthcare Private Limited

How many pharmaceutical products does BDH Healthcare Private Limited export from India?

BDH Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Celecoxib ($1.1M), Zinc ($350.0K). Total export value is $1.5M.

What is BDH Healthcare Private Limited's total pharmaceutical export value?

BDH Healthcare Private Limited's total pharmaceutical export value is $1.5M, based on 30 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does BDH Healthcare Private Limited cover?

BDH Healthcare Private Limited exports across 2 therapeutic categories. The largest are Analgesics & Antipyretics (76.7%, 1 products), Vitamins & Supplements (23.3%, 1 products).

Get Full BDH Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.